A synthetic short peptide from the Russian "bioregulator" research tradition, discussed in relation to cartilage and connective tissue. Prescribed online after a licensed provider reviews your online visit, compounded by U.S. 503A pharmacies, and shipped discreetly to most U.S. states.
$249
A few private questions, then a licensed provider reviews your answers.

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the short-peptide "bioregulator" research associated with the St. Petersburg Institute of Bioregulation and Gerontology, the same tradition as Epithalon. It is discussed in relation to cartilage and connective tissue.
The published work on Cartalax is limited, largely preclinical and from a small number of groups. It is not an FDA-approved medication and has not been shown to treat any condition in humans.
This is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. It is prescribed only where a licensed provider determines it is appropriate after reviewing your health history.
Cartalax comes up alongside other short bioregulator peptides such as Epithalon. The research behind it is limited and largely laboratory-based, and it does not establish a clinical benefit.
Every Cartalax prescription here follows a review by a licensed provider of your health history, current medications and goals. If it isn't appropriate for you, it isn't prescribed.
Your vial is compounded by a licensed U.S. 503A pharmacy and dispensed against a prescription written in your name — not sold as a "research only" product with no oversight.
The short answer: unregulated supplements make claims nobody checks, "research only" vials sold online carry no prescription, no pharmacy and no accountability, and a prescribed Cartalax is compounded by a licensed 503A pharmacy against a provider's order written for you.
| Oral supplement | "Research only" vial | Prescribed Cartalax (Rx) | |
|---|---|---|---|
| What it is | An unregulated oral precursor | A vial sold without a prescription | Compounded Cartalax dispensed on a provider's order |
| Licensed provider reviews you | No | No | Yes — before anything is dispensed |
| Compounded by a licensed pharmacy | No | No | Yes — U.S. 503A |
| Your name on the vial | No | No | Yes |
| Dose set by a prescriber | No | No | Yes |
| Legal to sell for human use | As a supplement | No | Yes — by prescription |
The simplest test of any peptide seller: is your name on the vial? A "research only" label means no prescriber reviewed you, no licensed pharmacy compounded it, and nobody is accountable for what is actually inside.
Three steps: answer a short set of medical questions, a licensed provider reviews them, and if they prescribe, a 503A pharmacy compounds and ships it.
A short private medical questionnaire — your history, current medications and what you are hoping to address. It takes a couple of minutes.
A provider licensed in your state reviews your answers online — no appointment, no waiting room. They decide whether Cartalax is appropriate.
If they prescribe, a licensed U.S. 503A pharmacy compounds your vial and ships it discreetly, with your name on the label.
It's for adults who want Cartalax prescribed and compounded properly rather than bought from a grey market. Whether it is appropriate for you is a decision for the provider who reviews your visit.
You have read about bioregulator peptides and want one prescribed properly rather than bought from a grey market.
Reviewed by a licensed provider, compounded by a 503A pharmacy, dispensed with your name on the vial.
The amount and schedule are set by your prescriber, not selected here or taken from a forum protocol.
Cartalax research is limited and largely preclinical.
Cartalax research is limited, largely preclinical and from a small number of groups. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. If you are pregnant or breastfeeding, have an active cancer diagnosis, or have significant kidney or liver disease, tell your provider in your answers. New or unexplained symptoms should be evaluated by a clinician rather than self-treated.
You answer a few questions, a licensed provider reviews your answers, and — if they prescribe — your medication is compounded and shipped to your door. No insurance required, no in-person appointment, no waiting room.
Answer a short set of private medical questions. Add as many peptides as you like; one checkout, and a provider reviews each.
A provider licensed in your state reviews your answers online. Approval is never guaranteed.
If prescribed, your vial is compounded by a 503A pharmacy and ships in plain, unmarked packaging to most U.S. states.
Pricing is shown at checkout — no insurance needed, no hidden fees.
Cartalax is compounded as injection. The amount and the schedule are set by the provider who reviews your visit — we deliberately do not publish a dosing regimen here, because that is a clinical decision about you, not a product specification.
Cartalax research is limited, largely preclinical and from a small number of groups. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.
Reported effects are most often related to the injection itself or to infusing too quickly. They can include:
Tell your provider about every condition and medication before starting, including pregnancy or breastfeeding. Stop and seek care for signs of an allergic reaction — rash, swelling of the face or throat, or difficulty breathing. For emergencies call 911.
A side-by-side look at the gh / longevity options available through ForbiddenRx. Which one is appropriate for you is decided by the provider who reviews your visit.
| Treatment | What it is | Focus | Form | For | Rx required |
|---|---|---|---|---|---|
| Cartalax This page | Synthetic tripeptide | Longevity category | Injection | Adults 18+ | Yes |
| 5-Amino-1MQ | Small-molecule NNMT inhibitor (oral) | Metabolic category | Capsules | Adults 18+ | Yes |
| AOD-9604 | Growth-hormone fragment (hGH 176-191) | Metabolic category | Injection | Adults 18+ | Yes |
| Epithalon | Synthetic tetrapeptide | Longevity category | Injection | Adults 18+ | Yes |
Cartalax is a synthetic three-amino-acid peptide from the Russian short-peptide "bioregulator" research tradition, discussed in relation to cartilage and connective tissue.
Very little. The published work is limited, largely preclinical and from a small number of research groups.
No. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.
No. You complete the questionnaire online and a licensed provider reviews it — there is no scheduling step and no waiting room.
Yes. Add each one to your cart and check out once. A provider reviews every treatment in your order.
U.S. board-certified clinicians
U.S.-based compounding partners
We confirm your state during intake
If you are going to take Cartalax, take one a licensed provider prescribed and a 503A pharmacy compounded with your name on it. Answer a few questions and a licensed provider reviews them.
Medically reviewed by ForbiddenRx Medical Affairs — Independent, licensed medical providers · Last reviewed August 2026. This page was written and is periodically reviewed for medical accuracy in line with clinical guidance followed by the independent, licensed medical providers in the ForbiddenRx network. It is provided for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk with a licensed provider about your individual health.
This page is educational and is not medical advice.